High-risk psychotropic medications for US children with trauma sequelae
- PMID: 30392479
- PMCID: PMC6998973
- DOI: 10.1017/S2045796018000616
High-risk psychotropic medications for US children with trauma sequelae
Abstract
Children exposed to trauma are predisposed to develop a number of mental health syndromes. They are prone to under-treatment with effective psychosocial interventions and over-treatment with high-risk psychotropic medications, especially polypharmacy and the use of antipsychotics for unapproved conditions. We review the evidence for psychosocial and pharmacological treatments for mental health problems associated with high exposure to childhood trauma - identifying those in foster care as an index group - and the frequency of high-risk pharmacological practices. We describe current efforts to reduce over-treatment of children with high-risk psychotropic medications and propose further recommendations to protect and provide effective care for these vulnerable children.
Keywords: Child psychiatry; evidence-based psychiatry; psychotropic drugs; trauma.
Similar articles
-
Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.BMC Psychiatry. 2020 Jun 11;20(1):294. doi: 10.1186/s12888-020-02661-6. BMC Psychiatry. 2020. PMID: 32527250 Free PMC article.
-
Psychotropic medication use in children and adolescents in an inpatient setting.Psychiatriki. 2011 Oct-Dec;22(4):314-9. Psychiatriki. 2011. PMID: 22271844
-
National trends in psychotropic medication polypharmacy in office-based psychiatry.Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175. Arch Gen Psychiatry. 2010. PMID: 20048220
-
Novel psychotropic medications in children: new toxicities to master.Pediatr Emerg Care. 2001 Jun;17(3):226-31. doi: 10.1097/00006565-200106000-00020. Pediatr Emerg Care. 2001. PMID: 11437154 Review. No abstract available.
-
Prolonged QT Interval in Patients Receiving Psychotropic Medications.J Am Psychiatr Nurses Assoc. 2020 Jul/Aug;26(4):344-353. doi: 10.1177/1078390319873049. Epub 2019 Sep 11. J Am Psychiatr Nurses Assoc. 2020. PMID: 31509051 Review.
Cited by
-
Findings from an expert focus group on psychotropic medication deprescribing practices for children and youth with complex needs.Front Child Adolesc Psychiatry. 2024 Nov 20;3:1481446. doi: 10.3389/frcha.2024.1481446. eCollection 2024. Front Child Adolesc Psychiatry. 2024. PMID: 39816603 Free PMC article.
-
Inter-class Concomitant Pharmacotherapy in Medicaid-Insured Youth Receiving Psychiatric Residential Treatment.Front Psychiatry. 2021 May 20;12:658283. doi: 10.3389/fpsyt.2021.658283. eCollection 2021. Front Psychiatry. 2021. PMID: 34093273 Free PMC article.
-
High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid.BMC Psychiatry. 2021 Jun 10;21(1):303. doi: 10.1186/s12888-021-03309-9. BMC Psychiatry. 2021. PMID: 34112146 Free PMC article.
References
-
- Barnett ER, Concepcion Zayas MT, Zisman-Ilani Y and Bellonci C (in press) Patient-centered psychiatric care for youth in foster care: a systematic and critical review. Journal of Public Child Welfare.
-
- Bellonci C and Carlson GA (2016) 24.0 deprescribing in child and adolescent psychiatry: where, when, and how to safely reduce polypharmacy in clinical settings. Journal of the American Academy of Child & Adolescent Psychiatry 55, S37.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical